The stark gap between trailing P/E (42.1x) and forward P/E (5.0x) is the most compelling metric; it implies the market anticipates a near‑term earnings surge of roughly 740%, which, if realized, would validate the discount and deliver outsized returns.
If the anticipated earnings acceleration fails and the company posts only modest growth, the forward P/E could revert toward historical levels (~70x), implying a potential 1,300% downside from current pricing; investors must monitor execution risk around new product rollouts and churn rates.
| Metric | Historical DCF | Analyst DCF |
|---|---|---|
| Growth Assumption | 3.5% (10Y CAGR) | Analyst Rev × 13.3% margin |
| PV of FCF | $683.0M | $507.8M |
| Terminal Value (PV) | $6.88B | $5.16B |
| Enterprise Value | $7.57B | $5.67B |
| Equity Value | $6.78B | $4.88B |
| Implied Stock Price | $104.81 | $75.45 |
| Upside/Downside | +1245.4% | +868.6% |
| WACC \ Growth | 2.5% | 3.0% | 3.5% | 4.0% | 4.5% |
|---|---|---|---|---|---|
| 3.5% | $228 | $459 | |||
| 4.5% | $108 | $145 | $219 | $441 | |
| 5.5% | $68 | $82 | $103 | $139 | $211 |
| 6.5% | $48 | $55 | $65 | $79 | $99 |
| 7.5% | $36 | $40 | $46 | $53 | $62 |
| WACC \ Growth | 2.5% | 3.0% | 3.5% | 4.0% | 4.5% |
|---|---|---|---|---|---|
| 3.5% | $168 | $341 | |||
| 4.5% | $78 | $106 | $161 | $328 | |
| 5.5% | $48 | $58 | $74 | $101 | $155 |
| 6.5% | $33 | $38 | $46 | $56 | $71 |
| 7.5% | $24 | $27 | $31 | $36 | $44 |
| Method | Implied Value | Upside/Downside | Basis |
|---|---|---|---|
| P/E (Peer) | $54.36 | +597.8% | Peer median P/E (35.2x) × Forward EPS ($1.54) |
| P/B (Peer) | $2.24 | -71.2% | Peer median P/B (1.83x) × Book Value per Share |
| EV/EBITDA (Peer) | $8.40 | +7.8% | Peer median EV/EBITDA (15.4x) × EBITDA - Net Debt |
| P/S (Peer) | $24.47 | +214.2% | Peer median P/S (3.60x) × Revenue per Share |
| DCF | $104.81 | +1245.4% | Revenue × FCF Margin projection |
| Analyst Target | $8.63 | +10.8% | Consensus of 15 analysts |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-07-31 · finexus.net